For subcutaneous vaccination of healthy dogs 9 weeks of age or older as an aid in the prevention of disease caused by Borrelia burgdorferi.
- Reduced-volume protection against Borrelia burgdorferi
- The first and only 0.5 ml canine Lyme disease vaccine - 50% less volume than standard vaccines
- Proven 92.2% effective against natural infection
- Exclusive Pure-Fil™ technology designed to reduce extraneous proteins and cellular debris
- Proven safe - even in Lyme positive dogs